📰 Given Zynex News
Given Zynex News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Zynex. Real-time updates on events, politics, business and more.
April 3, 2024
Galenica (OTCMKTS:GALNF – Get Free Report) and Zynex (NASDAQ:ZYXI – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, risk, earnings, valuation, institutional ownership and dividends. Valuation and Earnings This table compares Galenica and Zynex’s top-line […]
April 3, 2024
Zynex (NASDAQ:ZYXI – Get Free Report) and Galenica (OTCMKTS:GALNF – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations. Insider and Institutional Ownership 29.7% of Zynex shares are held […]
April 1, 2024
Zynex (NASDAQ:ZYXI – Get Free Report) and Galenica (OTCMKTS:GALNF – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability. Profitability This table compares Zynex and Galenica’s net margins, return […]
December 19, 2023
Zynex (NASDAQ:ZYXI – Get Free Report) and McKesson Europe (OTCMKTS:CAKFY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Profitability This table compares Zynex and McKesson Europe’s net […]
December 11, 2023
Zynex (NASDAQ:ZYXI – Get Free Report) and Vivani Medical (NASDAQ:VANI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Analyst Recommendations This is a breakdown of current […]
December 8, 2023
Zynex (NASDAQ:ZYXI – Get Free Report) and Vivani Medical (NASDAQ:VANI – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Risk & Volatility Zynex has a beta of […]
December 8, 2023
Vivani Medical (NASDAQ:VANI – Get Free Report) and Zynex (NASDAQ:ZYXI – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Earnings and Valuation This table compares Vivani Medical […]
November 28, 2023
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) and Zynex (NASDAQ:ZYXI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, risk, analyst recommendations, valuation and institutional ownership. Institutional & Insider Ownership 28.6% of Zynex shares […]
July 6, 2023
Zynex (NASDAQ:ZYXI – Free Report) and Soleno Therapeutics (NASDAQ:SLNO – Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk. Volatility and Risk Zynex has a beta of 0.57, suggesting […]
May 23, 2022
Zynex (NASDAQ:ZYXI – Get Rating) and Natus Medical (NASDAQ:NTUS – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Insider & Institutional Ownership 28.1% of Zynex shares are held […]